trending Market Intelligence /marketintelligence/en/news-insights/trending/31cnLgSgPwH_V3nKnMP6Lw2 content esgSubNav
In This List

1Life Healthcare plans Nasdaq IPO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


1Life Healthcare plans Nasdaq IPO

1Life Healthcare Inc. is planning an IPO to list its shares on the Nasdaq Global Select Market under the symbol ONEM.

The San Francisco-based company offers technology solutions to its members that enable access to physicians through video and mobile-based applications.

The company plans to use proceeds for general corporate purposes, including working capital, research and development, business development, sales and marketing activities as well as capital expenditures.

Tom Lee is the founder and CEO of 1Life Healthcare, and Sharon Knight is the company's president.

Asset management company The Carlyle Group LLC and Benchmark Capital Partners V LP own a 26.8% and 13% stake, respectively, in 1Life Healthcare.

J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC are the joint book-running managers for the IPO.